Fulcrum Therapeutics, Inc.: HC Wainwright Maintains Buy Recommendation







Marketzone with MT Newswires 2022

All the news about FULCRUM THERAPEUTICS, INC.

Analyst Recommendations on FULCRUM THERAPEUTICS, INC.

2022 turnover 11.1M

10.4M
2022 net result -110M

-103M
trso. net 2022 164M

153M
PER 2022-3.16x
2022 return
Capitalization 330M
330M
310M
VE / CA 202215.0x
VE / CA 20238.37x
Number of employees104
Floating92.1%

Chart FULCRUM THERAPEUTICS, INC.


Hard :

Period:




Fulcrum Therapeutics, Inc. : Chart technical analysis Fulcrum Therapeutics, Inc. |  Market area

Trends Technical Analysis FULCRUM THERAPEUTICS, INC.

Short termMiddle termLong term
TrendsbearishbearishNeutral

Evolution of the Income Statement

Sale

Purchase

Average recommendationTO BUY
Number of Analysts8
Last Closing Price$8.09
Average price target$30.25
Deviation / Average Target274%

Officers and Directors




Source link -88